Lomecel-B on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Public ClinicalTrials.gov record NCT02982915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effects of Intravenous Delivery of Lomecel-B (Formerly Allogenic Longeveron Human Mesenchymal Stem Cells (LMSCs)) on VaccinE-Specific Antibody Responses in Subjects With Aging Frailty
Study identification
- NCT ID
- NCT02982915
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Longeveron Inc.
- Industry
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Interventions
- Longeveron Mesenchymal Stem Cells (LMSCs) Biological
- Fluzone High Dose Vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 65 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2016
- Primary completion
- Aug 31, 2021
- Completion
- Aug 31, 2022
- Last update posted
- Nov 3, 2022
2016 – 2022
United States locations
- U.S. sites
- 6
- U.S. states
- 2
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research of South Florida | Coral Gables | Florida | 33134 | — |
| Clinical Physiology Associates | Fort Myers | Florida | 33912 | — |
| University of Miami | Miami | Florida | 33136 | — |
| Vista Health Research | Miami | Florida | 33176 | — |
| Johns Hopkins University | Baltimore | Maryland | 21224 | — |
| Optimal Research LLC | Rockville | Maryland | 20850 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02982915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 3, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02982915 live on ClinicalTrials.gov.